在初始评估时扩张性心肌病的聚类:为临床分层的有效工具
Ilaria Gandin1, Maria Perotto2, Alessia Paldino2
1Biostatistics Unit, Department of Medicine, Surgery and Health Science, University of Trieste, Trieste, Italy.
European journal of heart failure
|August 15, 2025
概括
机器学习使用基线心电图识别了两个扩展性心肌病 (DCM) 亚组. 这简化了DCM患者的风险分层,有助于更好地管理疾病并预测结果.
科学领域:
- 心脏病学 心脏病学
- 医疗信息学 医疗信息学
- 遗传学 遗传学 是一个
背景情况:
- 扩张性心肌病 (DCM) 呈现变化,复杂的风险分层.
- 目前的分层方法复杂,需要进行广泛的评估.
- 需要更简单,更有效的方法来早期DCM患者评估.
研究的目的:
- 使用机器学习 (ML) 在扩张性心肌病 (DCM) 患者中识别不同的子组.
- 根据初始心脏病学评估,开发一种简化方法来对DCM患者进行分层.
- 将已识别的子组与遗传背景和临床结果相关联.
主要方法:
- 对大量DCM患者队列的回顾性分析与基线临床,遗传和结果数据.
- 无监督的ML集群用于识别患者子组,然后使用关键心电图 (ECG) 变量进行简化.
- 在独立的外部队列中验证简化集群模型.
主要成果:
- 确定了两个DCM子组 (CL1和CL2),主要通过ECG特征进行区分.
- 与CL1相比,CL2显示了致病性/可能致病性变体的发病率较低 (15%vs. 47%).
- 一个简化的3变量心电图模型有效地识别了小组,并预测了CL2中突然心脏死亡/主要心室节律失常的风险较低.
结论:
- 对基线心电图变量的ML分析可以有效地划分DCM子组.
- 这些子组在遗传特征和疾病进展方面存在差异.
- 这种基于ML的基于心电图的方法为DCM患者的早期风险分层提供了有价值的工具.
更多相关视频
相关概念视频
Cardiomyopathy II: Dilated Cardiomyopathy
21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21
Cardiomyopathy III: Hypertrophic Cardiomyopathy
45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
Cardiomyopathy I: Introduction and Classification
49
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
49
Cardiomyopathy IV: Restrictive Cardiomyopathy
25
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
25
Cardiomyopathy V: Interprofessional Care
30
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
30
Mitral Stenosis II: Clinical features and Diagnostic Tests
36
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
36


